Corporate calendar for Bone Biologics Corporation (BBLG): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | $159M | |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | ||
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2025-06-10 | 1:6 |
| 2023-12-20 | 1:8 |
| 2023-06-07 | 1:30 |
| 2021-10-13 | 1:2 |
| 2020-11-02 | 1:10 |
| 2018-07-24 | 1:10 |
Price
| Price | $0.54 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Related companies: BDRX · DHAI · GCTK · HSCS · INM · MOVE · NAOV
Explore sector: Healthcare · Biotechnology
More sections of BBLG: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks